114 related articles for article (PubMed ID: 6432324)
1. In vitro properties of ceftazidime, a highly active broad-spectrum cephalosporin with antipseudomonal activity.
Harper PB
Clin Ther; 1984; 6(4):411-24. PubMed ID: 6432324
[TBL] [Abstract][Full Text] [Related]
2. Ceftazidime, a broad spectrum cephalosporin with activity against Ps. aeruginosa.
O'Callaghan H
J Hyg Epidemiol Microbiol Immunol; 1986; 30(4):449-53. PubMed ID: 3100612
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic use in neonatal sepsis.
Yurdakök M
Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
[TBL] [Abstract][Full Text] [Related]
4. Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
Smith BR
Clin Pharm; 1984; 3(4):373-85. PubMed ID: 6380902
[TBL] [Abstract][Full Text] [Related]
5. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
6. [In vitro comparative activity of 4 beta-lactams against Pseudomonas aeruginosa. Role of cefoperazone].
Joly-Guillou ML; Bergogne-Berezin E; Verin-Prevost C
Pathol Biol (Paris); 1984 May; 32(5):408-11. PubMed ID: 6429612
[TBL] [Abstract][Full Text] [Related]
7. [Monotherapy of systematic Pseudomonas aeruginosa infections with ceftazidime. The causes of therapeutic failures].
Blaser J; Bauernfeind A; Vogt M; Lüthy R
Dtsch Med Wochenschr; 1983 Sep; 108(35):1312-7. PubMed ID: 6411442
[TBL] [Abstract][Full Text] [Related]
8. [In vitro activity of ceftazidime compared with five beta-lactamase stable compounds against clinical strains of Acinetobacter calcoaceticus ].
Bergogne-Berezin E; Joly-Guillou ML; Verin-Prevost C
Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):506-9. PubMed ID: 6289227
[TBL] [Abstract][Full Text] [Related]
9. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
Ciofu O; Giwercman B; Pedersen SS; Høiby N
APMIS; 1994 Sep; 102(9):674-80. PubMed ID: 7946270
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activity.
Arisawa M; Sekine Y; Shimizu S; Takano H; Angehrn P; Then RL
Antimicrob Agents Chemother; 1991 Apr; 35(4):653-9. PubMed ID: 1906261
[TBL] [Abstract][Full Text] [Related]
11. Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agents.
Bell JM; Turnidge JD;
Pathology; 2001 Feb; 33(1):53-60. PubMed ID: 11280610
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of PER-1 producing clinical isolates of Pseudomonas aeruginosa in Japan and their susceptibility to doripenem.
Yamano Y; Nishikawa T; Fujimura T; Yutsudou T; Tsuji M; Miwa H
J Antibiot (Tokyo); 2006 Dec; 59(12):791-6. PubMed ID: 17323646
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics.
Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG
Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718
[TBL] [Abstract][Full Text] [Related]
14. Newer antipseudomonal cephalosporins.
Watanabe NA
J Chemother; 1996 Feb; 8 Suppl 2():48-56. PubMed ID: 8738846
[TBL] [Abstract][Full Text] [Related]
15. [Cefoperazone, cefsulodin and ceftazidime--3 cephalosporins active against Pseudomonas in comparison with their monobactam analogs].
Baumgärtner M
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Apr; 254(2):253-60. PubMed ID: 6326420
[TBL] [Abstract][Full Text] [Related]
16. [In vitro activity of a new cephalosporin--cefoperazone--against Enterobacteriaceae and Pseudomonas aeruginosa].
Modde H
Schweiz Med Wochenschr; 1981 Mar; 111(10):356-8. PubMed ID: 6452690
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial profile of ceftazidime: the situation in three larger hospitals in Prague between 1981 and 1983.
Hejzlar M; Sedmidubský V; Procházková A; Dvorský V; Stastná L; Paroubek M; Kotasová M; Puchmayerová M; Silarová J; Gleichová L
J Hyg Epidemiol Microbiol Immunol; 1984; 29(3):311-5. PubMed ID: 6443365
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
Krause R; Mittermayer H; Feierl G; Allerberger F; Wendelin I; Hirschl A; Reisinger EC
Wien Klin Wochenschr; 1999 Jul; 111(14):549-54. PubMed ID: 10467641
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
Fass RJ
Arch Intern Med; 1980 Jun; 140(6):763-8. PubMed ID: 7387270
[TBL] [Abstract][Full Text] [Related]
20. Preliminary study on the use of ceftazidime, a broad spectrum cephalosporin antibiotic, in snakes.
Lawrence K; Muggleton PW; Needham JR
Res Vet Sci; 1984 Jan; 36(1):16-20. PubMed ID: 6369458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
